Mycoplasma pneumoniae monoclonal antibodies

Mycoplasma pneumoniae is a parasitic pathogen of the human respiratory tract. This bacterium lacks a cell wall and thus many antibiotics that inhibit cell wall synthesis are ineffective as treatment. M. pneumoniae causes atypical pneumonia and affects children and young adults most commonly. The organism adheres to respiratory epithelial cells via several adhesins. The P1 adhesin is a major virulence factor of this organism.

ViroStat has now released a new set of monoclonal antibodies to the P1 adhesin of M. pneumoniae. These new antibodies function well in immunofluorescence antibody (IFA) staining and as enzyme-linked immunosorbent assay (ELISA) pairs for the detection of the P1 antigen. These antibodies join the existing collection of ViroStat M. pneumoniae antibody reagents.
www.virostat-inc.com
 

Other news

Learning from history

Upcoming Events

Lab Innovations

NEC, Birmingham (Hall 12)
30-31 October 2019

British Society for Immunology Congress

Arena and Convention Centre, Kings Dock, Liverpool Waterfront, Liverpool L3 4FP
2-5 December 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2019

Are you ready for the winter influenza season?

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.